Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress Post author:Sam Post published:August 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 2 Underappreciated Biotech Stocks to Buy in 2018 January 1, 2018 Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller September 14, 2017 Illumina Leaves Mission Bay for New Campus in the Peninsula February 15, 2018
Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller September 14, 2017